July 2nd 2024
The speed of adoption of new practices in medicine is extremely slow. We need systems to test new protocols, make sure they’re safe and effective, and get them out into the world more rapidly.
What Health Execs Need to Know about Tissue-Agnostic Cancer Drug Trials
August 17th 2018Basket trials are designed to test therapies that target a specific genetic mutation found in the tumor, regardless of tumor histology. This emerging trend raises a number of key questions for the industry.
Read More